Services on Demand
Journal
Article
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Ginecología y obstetricia de México
Print version ISSN 0300-9041
Abstract
BUITRON-GARCIA, FR; BAILON-URIZA, R; SANTOYO-HARO, S and DIAZ-SANCHEZ, V. Evidence in progesterone prescription. Ginecol. obstet. Méx. [online]. 2017, vol.85, n.8, pp.489-497. ISSN 0300-9041.
BACKGROUND:
Progesterone is a steroid hormone involved in ovulation, implantation, pregnancy and regulation of uterine function during the menstrual cycle and other organs such as the mammary gland. Because of its mechanism of action, progesterone is indicated in different gynecological and obstetric conditions: premenstrual syndrome, threatened abortion, preterm birth, dysfunctional uterine bleeding and mastalgia related to the menstrual cycle.
OBJECTIVE:
To evaluate the safety and efficacy of progesterone in patients with: premenstrual syndrome, threatened abortion, preterm birth, dysfunctional uterine bleeding, mastalgia and hormone therapy in menopause.
MATERIAL AND METHODS:
Systematic review of scientific evidence about different indications of progesterone.
RESULTS:
We found 92 articles from wich 41 were selected for review.
CONCLUSIONS:
The clinical evidence evaluated on different indications of progesterone demonstrates advantages in efficacy and safety in different regimens.
Keywords : Progesterone; Premenstrual syndrome; threatened miscarriage; Preterm birth; Mastalgia; Dysfunctional uterine bleeding; hormone therapy in menopause.
